Filter by Category:
Feb 05, 2021
Tenant Spotlight: Landos Biopharma Announce Positive Results from a Phase 1 Study of NX-13 | VT Corporate Research Center
Jan 28, 2021
Tenant Spotlight: KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program
Jan 05, 2021